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Background
Treatment of spondyloarthritis (SpA) has advanced
enormously in recent years, with anti-TNF treatment
taking a central role. National and international guide-
lines [1-3] suggest that anti-TNF treatment for ankylos-
ing spondylitis (AS) and psoriatic arthritis (PsA) should
be commenced where possible by a rheumatologist with
a specialist interest in these conditions. It is therefore
important that patients are reviewed by the appropriate
clinician where possible, and this is the rationale behind
the weekly Leeds SpA clinic.
Patients may be referred by their general practitioner
(GP) or community musculoskeletal services. Some are
referred from other medical specialties, notably dermatol-
ogy and gastroenterology. Referrals reach the clinic in two
ways: either via the “choose and book” system if directly
requested by GP, or by a general referral that is then
triaged by one of the six clinical rheumatology trainees in
Leeds. The Leeds SpA clinic is presently oversubscribed,
so appropriate identification of new patients to this specia-
list clinic is important. This audit sought to review refer-
rals to this clinic to assess the current efficacy of the
referral system.
Methods
A retrospective audit was performed, with appropriate
referral of SpA being the gold standard. New referrals
seen in the Leeds SpA clinic over a six month period
(June 2011-November 2011 inclusive) were reviewed
using electronic letters and electronic results server.
Audit approval was obtained from Leeds Teaching
Hospitals.
Results
75 new referrals were identified as having attended a
“new patient” appointment. The mean patient age was
41.13 years, with median 42.5 years. 41 of the referred
patients were male. 45 patients had a diagnosis of spon-
dyloarthritis, with the majority (n = 24) being diagnosed
with PsA. A total of 55 patients had features in the his-
tory that could be suggestive of a diagnosis of spondy-
loarthritis, with a personal history of psoriasis (n = 39)
being the most frequent. Two patients had a diagnosis
of connective tissue disease, presenting with back pain
and generalised arthralgia respectively. In total, eight
patients entered clinical trials following their first atten-
dance in clinic. Two patients had been referred for a
second clinical opinion; one for diagnostic and the other
for treatment opinions. Further analysis, including a
comparison of “choose and book” and triaged referrals,
will be presented at the meeting.
Discussion
The audit found that the majority of referrals to the Leeds
SpA clinic are appropriate. Indeed, even among the
patients with an eventual diagnosis of mechanical joint
pain, a number had risk factors for spondyloarthritis and
were reviewed in the appropriate setting. We can therefore
say that presentation to this clinic is reasonably specific.
However, the audit cannot assess the sensitivity of referral
of SpA within the service. This would require an audit of
all new referrals to the Leeds Rheumatology Service and
may be an avenue of further investigation.
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